Download
00423_2024_Article_3522.pdf 1,26MB
WeightNameValue
1000 Titel
  • Retromuscular, periprosthetic drainage after hernioplasty with sublay mesh reinforcement in ventral hernias results in less retromuscular fluid collections but longer hospital stay and analgetic use with unclear effect on clinical outcome - a randomized controlled trial
1000 Autor/in
  1. Pochhammer, Julius |
  2. Ibald, Caroline |
  3. Weller, Marie-Pascale |
  4. Schäffer, Michael |
1000 Verlag Springer Berlin Heidelberg
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-11-05
1000 Erschienen in
1000 Quellenangabe
  • 409(1):334
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00423-024-03522-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538186/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>To determine whether periprosthetic drain insertion for hernioplasty using sublay mesh augmentation influences retromuscular fluid collections (RFC) and the clinical course.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Forty-two patients with open repair of midline hernias (M2-4, W1, European Hernia Society classification) were allocated to groups with or without retromuscular drains. Subcutaneous drainages were used in both groups to avoid confounding from surgical site occurrences due to superficial, subcutaneous fluid collections. The participants underwent clinical and ultrasound assessments on postoperative days (POD) 14 and 30 to detect RFC, subcutaneous seromas, and wound complications. The sample size was estimated using the RFC of a test cohort with drainage; the assumed relevant volume (5 ml) was calculated comprising 84% (mean + 1 SD) of these patients.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>In the retromuscular drainage group, the RFC median volume was reduced by 75.2% on POD 14, and by POD 30, no RFC were found [0.2 vs. 25.8 (<jats:italic>p</jats:italic> &lt; 0.001) and 0 vs. 4.0 (<jats:italic>p</jats:italic> = 0.02) on PODs 14 and 30, respectively]. The number of patients with RFC ≥ 5 mL was also significantly lower in the drainage group [4 vs. 12 (<jats:italic>p</jats:italic> = 0.02) and 1 vs. 8 (<jats:italic>p</jats:italic> = 0.02) on PODs 14 and 30, respectively]. No surgical site infections occurred in either group, but retromuscular hematoseroma led to one revision surgery and one needle aspiration in the group without drainage. In the drainage group, a significantly longer hospital stay (6.5 days vs. 4 days; <jats:italic>p</jats:italic> = 0.01) and longer regular analgetic intake (6 vs. 3 days; <jats:italic>p</jats:italic> = 0.03) were observed. Multivariable regression revealed that retromuscular drainage usage was the only independent predictor of the RFC volume.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>We found that the use of retromuscular drains after hernioplasty with sublay hernia repair reduced periprosthetic fluid collections in our population but prolonged hospital stay. Whether the reduction of RFC can prevent SSO or revision surgery cannot be determined from our data, the relevance is therefore not assessable. Hence, further larger studies are required to determine the clinical relevance of drains.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Female [MeSH]
lokal Aged [MeSH]
lokal Retromuscular fluid collection seroma
lokal Adult [MeSH]
lokal Sublay hernia repair
lokal Humans [MeSH]
lokal Treatment Outcome [MeSH]
lokal Middle Aged [MeSH]
lokal Drainage/methods [MeSH]
lokal Hernia, Ventral/surgery [MeSH]
lokal Herniorrhaphy/adverse effects [MeSH]
lokal Surgical Mesh [MeSH]
lokal SSI
lokal SSO
lokal Male [MeSH]
lokal Research
lokal Drainage
lokal Postoperative Complications/etiology [MeSH]
lokal Length of Stay [MeSH]
lokal Herniorrhaphy/methods [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UG9jaGhhbW1lciwgSnVsaXVz|https://frl.publisso.de/adhoc/uri/SWJhbGQsIENhcm9saW5l|https://frl.publisso.de/adhoc/uri/V2VsbGVyLCBNYXJpZS1QYXNjYWxl|https://frl.publisso.de/adhoc/uri/U2Now6RmZmVyLCBNaWNoYWVs
1000 Hinweis
  • DeepGreen-ID: fa04dd76f99745c48ed2ea0e7a880b48 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Universitätsklinikum Schleswig-Holstein - Campus Kiel |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Universitätsklinikum Schleswig-Holstein - Campus Kiel |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6508554.rdf
1000 Erstellt am 2025-02-06T17:42:38.189+0100
1000 Erstellt von 322
1000 beschreibt frl:6508554
1000 Zuletzt bearbeitet 2025-09-14T19:31:03.556+0200
1000 Objekt bearb. Sun Sep 14 19:31:03 CEST 2025
1000 Vgl. frl:6508554
1000 Oai Id
  1. oai:frl.publisso.de:frl:6508554 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source